Clinical Trials Related to GlaxoSmithKline

Related studies linked through entity extraction aliases.

Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.

Status: COMPLETED
Phase: N/A

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Status: COMPLETED
Phase: N/A

Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age

Status: COMPLETED
Phase: PHASE2

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

Status: COMPLETED
Phase: PHASE1

Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years

Status: COMPLETED
Phase: N/A

Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study

Status: COMPLETED
Phase: N/A

Subject Insights to Understand the Hand Osteoarthritis (HOA)

Status: COMPLETED
Phase: N/A

A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices

Status: COMPLETED
Phase: PHASE2

A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses

Status: COMPLETED
Phase: PHASE1

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors

Status: WITHDRAWN
Phase: PHASE2

A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity

Status: COMPLETED
Phase: PHASE3

Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

Status: COMPLETED
Phase: PHASE1

A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B

Status: COMPLETED
Phase: PHASE4

Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)

Status: TERMINATED
Phase: PHASE2

Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma

Status: COMPLETED
Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults

Status: TERMINATED
Phase: PHASE1

Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies

Status: COMPLETED
Phase: PHASE2

Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients

Status: TERMINATED
Phase: PHASE1

The Economic Burden of Asthma in Canada

Status: COMPLETED
Phase: N/A